Bryan Harder

Brusatol overcomes chemoresistance through inhibition of protein translation

Bryan Harder, Tian Wang, James J. La Clair et al. · Molecular Carcinogenesis · 2016 · 126 citations · Full text

Oxidative stress, mammospheres and Nrf2–new implication for breast cancer therapy?

Tongde Wu, Bryan Harder, Pak Kin Wong et al. · Molecular Carcinogenesis · 2014 · 114 citations · Full text

Reduced Nrf2 expression mediates the decline in neural stem cell function during a critical middle‐age period

Mandi J. Corenblum, Sneha Ray, Quentin W. Remley et al. · Aging Cell · 2016 · 97 citations · Full text

Aging, Brain Development, Stem Cell Biology +17

Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis

Stephen T. Oh, Ruben A. Mesa, Claire Harrison et al. · Blood Advances · 2023 · 60 citations · Full text

Antifibrotic Therapy, Immunology, Cardiovascular Pharmacology +17

Low-level arsenic causes proteotoxic stress and not oxidative stress

Matthew Dodson, Montserrat Rojo de la Vega, Bryan Harder et al. · Toxicology and Applied Pharmacology · 2018 · 55 citations

Reductive Stress, Biochemistry, Medicine +6